SurgOnc Today®

In this episode, join the SSO HPB disease site working group as they count down the final five studies in the 2025 HPB wrapped. This episode dives into some of the year's most practice-changing publications in HPB surgical oncology: the ROC'N'ROLL Trial, best practices neoadjuvant therapy for pancreas cancer, the PANDRA-II Trial, the use of SBRT for resectable pancreas cancer, and the PREHEP Trial. Hear our guests Dr. Colin Court and Dr. Winnie Lo as they review the studies and unpack what these findings mean for clinical practice.

In this new episode of Speaking of SurgOnc, Dr. Rick Greene discusses with Dr. Lily Owei and Dr. Heather Wachtel key principles regarding the understanding and management of adrenal incidentalomas, as reported in the article, "The Landmark Series: Evaluation and Management of Adrenal Incidentalomas."

Family planning and fertility preservation can pose challenges for trainees and new surgical oncology attendings. The SSO Fellows and Young Attendings Committee tackles these topics within a three-part podcast. On this episode of SurgOnc Today, hosts Dr. Danielle Graham and Dr. Paige Aiello discuss fertility preservation techniques and other considerations with reproductive endocrinologist Dr. Nicole Budrys and surgeons Dr. Alisa Blumenthaler and Dr. Jordan Jackson.

In this episode, Dr. Jeffrey E. Gershenwald discusses the critical role surgical oncologists play in advancing evidence-based public policy. Using the FDA's black-box warning on indoor tanning for minors as a case study, Dr. Gershenwald highlights the science behind melanoma risk in adolescents and why advocacy is essential to protecting the next generation. Tune in to explore how policy action, prevention, and oncology expertise intersect, and why your voice as an SSO member matters beyond the operating room.

With updated thyroid cancer guidelines, adjunct diagnostic and treatment tools, and growing interest in minimalist approaches, it is increasingly challenging to know the optimal management for patients with small, differentiated thyroid cancer including when to refrain from operating. In this episode, we discuss the nuanced decision making in managing these patients, the multiple factors that are taken into consideration, and strategies in conducting efficacious conversations with patients. Hear from our world-renowned expert panel, Dr. Michael Tuttle, Professor and Chief of Endocrinology at Memorial Sloan Kettering Cancer Center, and Dr. Douglas Fraker, The Jonathan Rhoads Professor of Surgery Emeritus at the University of Pennsylvania , moderated by Dr. Mahsa Javid, Endowed Chair in Endocrine Surgery.

Family planning and fertility preservation can pose challenges for trainees and new surgical oncology attendings. The SSO Fellows and Young Attendings Committee tackles these topics within a three-part podcast. In this episode of SurgOnc Today, Julia Selfridge, MD, is joined by Dr. Madalyn Neuwirth and Dr. Ben Deschner, to discuss planning a family as a new attending.

On this episode of SurgOnc Today, SSO GI Disease Site Working Group members Dr. Brett Ecker, Dr. Prejesh Philips and Dr. Marion Liu review the latest data on molecular subtypes of ampullary cancer with invited guest and researcher Dr Jesper Anderson, Tenured Professor at the University of Copenhagen. Dr. Anderson discusses his recent publication in Gut, and how his findings change our understanding of this rare disease. https://pubmed.ncbi.nlm.nih.gov/39725462/

Family planning and fertility preservation can pose challenges for trainees and new surgical oncology attendings. The SSO Fellows and Young Attendings Committee tackles these topics within a three-part podcast. In this episode of SurgOnc Today, Julia Chandler, MD is joined by Dr. Helene Sterbling and Dr. Devon Freudenberger to discuss pregnancy and parenthood while in surgical training.

In this episode of Outside the OR with Berman, Dr. Russell Berman sits down with Dr. Peter Kingham to talk about the rising global cancer burden and why it matters to every surgical oncologist — and every patient. Drawing from his extensive work in West Africa and his leadership in global surgery, Dr. Kingham shares what cancer care really looks like in low-resource settings and how individual surgeons can make a meaningful impact. From groundbreaking research to on-the-ground challenges, this conversation shines a light on global cancer disparities. Tune in for an eye-opening, inspiring discussion about the future of cancer care worldwide.

In this episode of SurgOnc Today, SSO Breast Disease Site Working Group members Drs. David Anderson, Fred Dirbas, and Suzanne Klimberg dive into management of male breast cancer. The speakers discuss unique considerations for this population as well as the similarities and overlap when treating female breast cancer.

In this new episode of Speaking of SurgOnc, Dr. Rick Greene discusses with Dr. Mecker G. Möller crucial questions regarding colorectal peritoneal metastasis (CRC-PM) management, particularly concerning the optimal applications of HIPEC in clinical practice, as reported in the article, "Great Debate: Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases—Should It Be Offered?"

In this episode of SurgOnc Today, Jonathan Baines, MD, Donald Warne, MD, and Lori Arviso Alvord, MD discuss advocacy and mentoring of Native American and URM Trainees.

In this episode of SurgOnc Today, Mark Knab, Charles Vining, and Kelvin Allenson discuss how the anatomic location of duodenal adenocarcinoma—from the first to the fourth portion—fundamentally shapes surgical decision-making. Discussion highlights include criteria for pancreaticoduodenectomy versus segmental or limited resections, the role of margin status and lymphadenectomy, and evolving data guiding resection strategy for non-ampullary duodenal cancers. Designed for practicing surgical oncologists, this episode emphasizes operative judgment, outcomes data, and the balance between oncologic adequacy and surgical morbidity.

In this episode of SurgOnc Today, the SSO HPB disease site working group reviews strategies for implementation of histothripsy ablation in the management of liver primary and secondary malignancies, including a discussion of the evidence supporting it and support from the IDEAL framework for the adoption of surgical innovations into clinical practice. To do so, Drs. Miral Sadaria Grandhi and Zhi Ven Fong, members of the HPB disease site working group, are joined by Drs. Hop Tran Cao, Brock Hewitt, and Jeffrey Barkun.

Drs. Kavita Vakharia, surgical oncologist from City of Hope, Dr Sara Bateni, surgical oncologist at University of Alabama at Birmingham, Dr Nikhil Khushalanai, medical oncologist at the H. Lee Moffitt Cancer Center and James Jakub, surgical oncologist at the Mayo Clinic, Florida, discuss their current practice regarding multidisciplinary management of melanoma with a focus on the role of adjuvant systemic therapy for stages IIB, IIC and IIIA disease.

In this new episode of Speaking of SurgOnc, Dr. Rick Greene discusses with Dr. Helen Johnson and Dr. Katrina Mitchell the management of patients with breast cancer diagnosed during pregnancy or lactation, and guidance provided regarding surgery, radiation, and systemic therapy, as reported in the article, "Oncolactation for Patients with Breast Cancer: Executive Summary from the American Society of Breast Surgeons.”

On this episode of SurgOnc today, Dr. Rosalinda Alvarado and Dr. George Molina moderate a discussion on how to improve the recruitment of Hispanic/Latino patients into clinical trials. Joining the conversation are Jeanette Gonzalez from the University of Illinois Cancer Center and Alas-Wings, Dr. Narjust Florez from Dana-Farber Cancer Institute and Harvard Medical School, and Dr. Kennedy Timothy from MedStar Health and Georgetown University.

On this episode of SurgOnc Today, Mr. Myles Smith, Dr. Hari Deshpande, Dr. Alexandra Istl, & Dr. Danielle Cunningham will discuss the treatment of two rare subtypes of sarcoma, highlighting the differences and challenges of diagnosis and treatment. Both types may represent potentially curable cancers and should always be managed, if possible, by a multidisciplinary tertiary center.